Pfam Domains GO Terms
| dCMP cyt deam 1 |
| dCMP deaminase activity |
| dTMP biosynthetic process |
| dUMP biosynthetic process |
| dTMP metabolic process |
| importin-alpha family protein binding |
| pyrimidine deoxyribonucleoside monophosphate biosynthetic process |
| dUMP metabolic process |
| pyrimidine deoxyribonucleoside monophosphate metabolic process |
| DNA cytosine deamination |
| pyrimidine deoxyribonucleotide biosynthetic process |
| deoxyribonucleoside monophosphate biosynthetic process |
| cytidine catabolic process |
| cytidine metabolic process |
| cytidine deamination |
| deoxyribose phosphate biosynthetic process |
| 2-deoxyribonucleotide biosynthetic process |
| cytidine deaminase activity |
| pyrimidine ribonucleoside catabolic process |
| DNA deamination |
| deoxyribonucleoside monophosphate metabolic process |
| pyrimidine ribonucleoside metabolic process |
| deoxyribonucleotide biosynthetic process |
| pyrimidine nucleoside monophosphate biosynthetic process |
| pyrimidine nucleoside monophosphate metabolic process |
| pyrimidine deoxyribonucleotide metabolic process |
| ribonucleoside catabolic process |
| pyrimidine nucleoside catabolic process |
| 2-deoxyribonucleotide metabolic process |
| deoxyribose phosphate metabolic process |
| nucleoside catabolic process |
| deoxyribonucleotide metabolic process |
| pyrimidine nucleoside metabolic process |
| nucleoside monophosphate biosynthetic process |
| pyrimidine-containing compound catabolic process |
| glycosyl compound catabolic process |
| pyrimidine nucleotide biosynthetic process |
| nucleobase-containing small molecule catabolic process |
| pyrimidine-containing compound biosynthetic process |
| pyrimidine nucleotide metabolic process |
| nucleoside monophosphate metabolic process |
| ribonucleoside metabolic process |
| DNA modification |
| pyrimidine-containing compound metabolic process |
| nucleoside metabolic process |
| glycosyl compound metabolic process |
| carbohydrate derivative catabolic process |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| nucleobase-containing compound catabolic process |
| heterocycle catabolic process |
| cellular nitrogen compound catabolic process |
| small molecule catabolic process |
| aromatic compound catabolic process |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| organic cyclic compound catabolic process |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| carbohydrate derivative biosynthetic process |
| DNA metabolic process |
| zinc ion binding |
| protein homodimerization activity |
| organophosphate metabolic process |
| carbohydrate derivative metabolic process |
| organonitrogen compound catabolic process |
| nucleobase-containing compound biosynthetic process |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| organic cyclic compound biosynthetic process |
| organonitrogen compound biosynthetic process |
| cellular nitrogen compound biosynthetic process |
| small molecule metabolic process |
| organic substance catabolic process |
| cellular catabolic process |
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
| Screen | Score |
|---|---|
| Rifampicin 10μM R00 exp32 | 1.74 |
| Ibrutinib 1μM R07 exp372 | 1.83 |
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 0/28 |
| blood | 0/28 |
| bone | 0/26 |
| breast | 0/33 |
| central nervous system | 0/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 0/21 |
| liver | 0/20 |
| lung | 0/75 |
| lymphocyte | 0/16 |
| ovary | 0/26 |
| pancreas | 0/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 0/15 |
| prostate | 0/1 |
| skin | 0/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 0/29 |
| uterus | 0/5 |
Expression Distribution